Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 1, 2011, Pages

  Busse, William W ^a,k   Peters, Stephen P ^b   Fenton, Matthew J ^c   Mitchell, Herman ^d   Bleecker, Eugene R ^b   Castro, Mario ^e   Wenzel, Sally ^f   Erzurum, Serpil C ^g   Fitzpatrick, Anne M ^h   Teague, W Gerald ⁱ   Jarjour, Nizar ^a   Moore, Wendy C ^b   Sumino, Kaharu ^e   Simeone, Scott ^f   Ratanamaneechat, Suphagaphan ^g   Penugonda, Madhuri ^h   Gaston, Benjamin ⁱ   Ross, Ted M ^j   Sigelman, Steve ^c   Schiepan, Joella R ^d   Zaccaro, Daniel J ^d   Crevar, Corey J ^j   Carter, Donald M ^j   Togias, Alkis ^c   more..

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d Rho Federal Systems Division Inc   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h EMORY UNIVERSITY   (United States)

ⁱ UNIVERSITY OF VIRGINIA CHILDREN S HOSPITAL   (United States)

^j UNIVERSITY OF PITTSBURGH   (United States)

^k University of Wisconsin Health   (United States)

more..

Author keywords

asthma; H1N1; influenza; seroprotection; severe asthma; vaccine

Indexed keywords

FLUTICASONE; INACTIVATED VACCINE; INFLUENZA A H1N1 VACCINE; INFLUENZA VACCINE; MONOVALENT CATION; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOGENICITY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; LUNG FUNCTION; MALE; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEROCONVERSION;

EID: 78650859897     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.11.014     Document Type: Article

References (32)

1. CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009-March 13, 2010 2010 Centers for Disease Control and Prevention Atlanta
2. S. Jain, L. Kamimoto, A.M. Bramley, A.M. Schmitz, S.R. Benoit, and J. Louie Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009 N Engl J Med 361 2009 1935 1944
3. 2009 H1N1 Flu: underlying health conditions among hospitalized adults and children February 24, 2010 Centers for Disease Control and Prevention Available at: http://www.cdc.gov/H1N1flu/eip-underlying-conditions.htm Accessed September 17, 2009
4. B. Bloom, R.A. Cohen, and G. Freeman Summary health statistics for U.S. children: National Health Interview Survey, 2008. National Center for Health Statistics Vital Health Stat 244 2009 1 81
5. J.R. Pleis, J.W. Lucas, and B.W. Ward Summary health statistics for U.S. adults: National Health Interview Survey, 2008. National Center for Health Statistics Vital Health Stat 242 2009 1 157
6. W.W. Busse, R.F. Lemanske Jr., and J.E. Gern Role of viral respiratory infections in asthma and asthma exacerbations Lancet 376 2010 826 834
7. M.R. Sears, and N.W. Johnston Understanding the September asthma epidemic J Allergy Clin Immunol 120 2007 526 529
8. A.E. Fiore, D.K. Shay, K. Broder, J.K. Iskander, T.M. Uyeki, and G. Mootrey Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008 MMWR Recomm Rep 57 RR-7 2008 1 60
9. National Heart, Lung, and Blood Institute. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma - full report 2007. August 28, 2007. Available at: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed December 7, 2009.
10. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA). Available at: http://www.ginasthma.com/. Accessed November 10, 2010.
11. The American Lung Association Asthma Clinical Research Centers The safety of inactivated influenza vaccine in adults and children with asthma N Engl J Med 345 2001 1529 1536
12. N.A. Hanania, M. Sockrider, M. Castro, J.T. Holbrook, J. Tonascia, and R. Wise Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy J Allergy Clin Immunol 113 2004 717 724
13. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society Am J Respir Crit Care Med 162 2000 2341 2351
14. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research Guidance for industry: clinical data needed to support the licensure of pandemic influenza vaccines 2007 US Food and Drug Administration Washington (DC)
15. World Health Organization manual on animal influenza diagnosis and surveillance. Available at: http://whqlibdoc.who.int/hq/2002/WHO-CDS-CSR-NCS- 2002.5.pdf. Accessed November 10, 2010.
16. T.W. Clark, M. Pareek, K. Hoschler, H. Dillon, K.G. Nicholson, and N. Groth Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine N Engl J Med 361 2009 2424 2435
17. M.E. Greenberg, M.H. Lai, G.F. Hartel, C.H. Wichems, C. Gittleson, and J. Bennet Response to a monovalent 2009 influenza A (H1N1) vaccine N Engl J Med 361 2009 2405 2413
18. F.C. Zhu, H. Wang, H.H. Fang, J.G. Yang, X.J. Lin, and X.F. Liang A novel influenza A (H1N1) vaccine in various age groups N Engl J Med 361 2009 2414 2423
19. E. Plennevaux, E. Sheldon, M. Blatter, M.K. Reeves-Hoche, and M. Denis Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials Lancet 375 2010 41 48
20. K. Goodwin, C. Viboud, and L. Simonsen Antibody response to influenza vaccination in the elderly: a quantitative review Vaccine 24 2006 1159 1169
21. J.E. McElhaney The unmet need in the elderly: designing new influenza vaccines for older adults Vaccine 23 suppl 1 2005 S10 S25
22. A.R. Falsey, J.J. Treanor, N. Tornieporth, J. Capellan, and G.J. Gorse Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older J Infect Dis 200 2009 172 180
23. W.A. Keitel, R.L. Atmar, T.R. Cate, N.J. Petersen, S.B. Greenberg, and F. Ruben Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons Arch Intern Med 166 2006 1121 1127
24. C.E. Oh, J. Lee, J.H. Kang, Y.J. Hong, Y.K. Kim, and H.J. Cheong Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: a prospective, open-label, multi-center trial Vaccine 28 2010 5857 5863
25. W.A. Keitel, T.R. Cate, and R.B. Couch Efficacy of sequential annual vaccination with inactivated influenza virus vaccine Am J Epidemiol 127 1988 353 364
26. J. Treanor, W. Keitel, R. Belshe, J. Campbell, G. Schiff, and K. Zangwill Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults Vaccine 20 2002 1099 1105
27. W.C. Moore, and S.P. Peters Severe asthma: an overview J Allergy Clin Immunol 117 2006 487 495
28. D.M. Fleming, P. Crovari, U. Wahn, T. Klemola, Y. Schlesinger, and A. Langussis Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma Pediatr Infect Dis J 25 2006 860 869
29. W.P. Glezen Asthma, influenza, and vaccination J Allergy Clin Immunol 118 2006 1199 1208
30. R. Bergen, S. Black, H. Shinefield, E. Lewis, P. Ray, and J. Hansen Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents Pediatr Infect Dis J 23 2004 138 144
31. MedImmune, LLC. FluMist influenza vaccine live, intranasal. Highlights of prescribing information. Available at: http://www.medimmune.com/pdf/products/ flumist-pi.pdf. Accessed November 10, 2010.
32. A. Togias Rhinitis and asthma: evidence for respiratory system integration J Allergy Clin Immunol 111 2003 1171 1184